News und Analysen
Lumen: Among Top Performers Last Month, Still Has Warning Signs
Lumen Technologies (NYSE: LUMN) has experienced skyrocketing share price in the last month, making it one of the top-performing stocks based on total 30-day returns in the area of 323% as of
Baidu's Strong Quarter Proves a Smart Pick for Michael Burry
Recently, investors have had the chance to gain insight into the portfolios of Wall Street’s mega investors, from Warren Buffett and his multi-billion dollar positions and portfolio shifts to
Baidu's Strong Quarter Proves a Smart Pick for Michael Burry
Recently, investors have had the chance to gain insight into the portfolios of Wall Street’s mega investors, from Warren Buffett and his multi-billion dollar positions and portfolio shifts to
Intuit Beats Q4 Earnings: AI, Dividends, and a Growth Strategy
Intuit Inc. (NASDAQ: INTU) is the financial technology powerhouse behind TurboTax, Credit Karma, QuickBooks, and Mailchimp. The company continues to demonstrate its dominance in the market with
Intuit Beats Q4 Earnings: AI, Dividends, and a Growth Strategy
Intuit Inc. (NASDAQ: INTU) is the financial technology powerhouse behind TurboTax, Credit Karma, QuickBooks, and Mailchimp. The company continues to demonstrate its dominance in the market with
Intuit Beats Q4 Earnings: AI, Dividends, and a Growth Strategy
Intuit Inc. (NASDAQ: INTU) is the financial technology powerhouse behind TurboTax, Credit Karma, QuickBooks, and Mailchimp. The company continues to demonstrate its dominance in the market with
Ross Stores Investors Win Big as Off-Price Retailers Outperform
Unsurprisingly, off-price retailers like Ross Stores (NASDAQ: ROST) and TJX Companies (NYSE: TJX) outperform. The off-price retail segment is well-positioned after years of economic turmoil
Moderna erhält von der Europäischen Kommission die Genehmigung für den RSV-Impfstoff mRESVIA(R)
CAMBRIDGE, MASSACHUSSETTS / ACCESSWIRE / 23. August 2024 / Moderna, Inc. (NASDAQ: MRNA) hat heute bekannt gegeben, dass die Europäische Kommission (EC) die Marktzulassung für mRESVIA
Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R)
CAMBRIDGE, MA / ACCESSWIRE / August 23, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for mRESVIA® (mRNA-1345), an
Diabetes and Neuro Products Ignite Medtronic’s Q1 Earnings Rally
Shares of medical device manufacturer Medtronic PLC (NYSE: MDT) are down about 35% from their highs of roughly three years ago, but promising results from the company's first quarter of fiscal
Advance Auto Parts Eyes Long-Term Growth Despite Q2 Hurdles
Advance Auto Parts (NYSE: AAP) witnessed a dramatic plunge in its stock price, falling over 20% in pre-market trading after the company released its second-quarter 2024 earnings report. The
Toll Brothers Stock Up on Q3 Beat: Luxury Homes Drive Growth
Toll Brothers (NYSE: TOL) is one of the largest home-building companies in the United States. In 2023, the company's revenue was nearly $10 billion, putting it in fourth place behind giants like
4 No-Brainer Stocks to Hold This Fall for Steady Gains
When markets get volatile, investors of any size and background tend toward certainty in business models and predictability in cash flows. Fitting this category are stocks in the consumer staples
4 No-Brainer Stocks to Hold This Fall for Steady Gains
When markets get volatile, investors of any size and background tend toward certainty in business models and predictability in cash flows. Fitting this category are stocks in the consumer staples
4 No-Brainer Stocks to Hold This Fall for Steady Gains
When markets get volatile, investors of any size and background tend toward certainty in business models and predictability in cash flows. Fitting this category are stocks in the consumer staples
4 No-Brainer Stocks to Hold This Fall for Steady Gains
When markets get volatile, investors of any size and background tend toward certainty in business models and predictability in cash flows. Fitting this category are stocks in the consumer staples
McDonald's Stock Nearing New High After Analyst Price Boost
Investors might have avoided some consumer discretionary stocks due to growing inflation concerns and rising credit card delinquency rates. When personal finance conditions become so tight
Why Salesforce Stock Could Be About To Rally 20%
While it was scary at the time, the sell-off that started last month across equities is already becoming a thing of the past. Take the benchmark S&P 500 Index, for example. Sure, it had its worst
The Rally in TJX Companies Stock is Far From Over
TJX Companies (NYSE: TJX) stock price surged following the Q2 earnings release because its quality operations and market conditions combined to drive better-than-expected results, leading to
Flowers Foods’ Q2 Earnings: Is Now the Right Time to Invest?
Packaged bakery goods maker Flowers Foods Inc. (NYSE: FLO) reported mixed results for the second quarter as revenue fell by under 1% to $1.2 billion, failing to meet analyst predictions, and
Mawson Finland stellt Update zu den Explorationsaktivitäten bei Rajapalot bereit
TORONTO, Kanada, 21. August 2024 — Mawson Finland Limited („Mawson“ oder das „Unternehmen“) (TSX-V: MFL) freut sich bestätigen zu können, dass das Unternehmen sein erstes Bohrprogramm auf dem
Target Hits the Mark: Q2 Earnings Exceed Expectations
Target Corporation (NYSE: TGT) recently released its earnings report for the second quarter of 2024. The company’s latest report exceeded the expectations of its analyst community, prompting a
Is Tesla’s Rebound Just Starting? Why You Should Consider Buying
The late July and early August sell-off may have spooked many investors, but it also opened up some very tempting entry opportunities. Already, we’re seeing market-wide recovery rallies reclaim
Is Tesla’s Rebound Just Starting? Why You Should Consider Buying
The late July and early August sell-off may have spooked many investors, but it also opened up some very tempting entry opportunities. Already, we’re seeing market-wide recovery rallies reclaim
Stanley Druckenmiller's Latest Bet: MELI—Should You Follow Suit?
Stanley Druckenmiller, a renowned investor with a stellar track record, has made headlines with his family office, Duquesne, selling its position in NVIDIA (NASDAQ: NVDA) after accurately